Skip to main content
. 2019 Nov 5;19(3):e209–e216. doi: 10.18295/squmj.2019.19.03.006

Table 2.

Surgical and pathological characteristics of women with non-metastatic triple-negative breast cancer at the Sultan Qaboos University Hospital, Muscat, Oman (N = 79)

Characteristic n (%)
Type of surgery
Modified radical mastectomy 31 (39.2)
BCS and ALND 23 (29.1)
BCS and SLN 14 (17.7)
Skin-sparing mastectomy and ALND 3 (3.8)
Simple mastectomy and SLN 1 (1.3)
None 7 (8.9)
Pathological type
Infiltrating ductal carcinoma 77 (97.5)
Infiltrating lobular carcinoma 1 (1.3)
Micropapillary carcinoma 1 (1.3)
Pathological tumour size
T0 8 (10.1)
T1 17 (21.5)
T2 31 (39.2)
T3 12 (15.2)
T4 5 (6.3)
Unknown 6 (7.6)
Pathological node status
N0 37 (46.8)
Nmic 1 (1.3)
N1 17 (21.5)
N2 10 (12.7)
N3 7 (8.9)
Unknown 7 (8.9)
Pathological stage
pCR to chemotherapy 6 (7.6)
I 9 (11.4)
II 37 (46.8)
III 20 (25.3)
Unknown 7 (8.9)
Pathological grade
I 2 (2.5)
II 12 (15.2)
III 61 (77.2)
Unknown 4 (5.1)
Lymphovascular invasion
No 38 (48.1)
Yes 24 (30.4)
Unknown 17 (21.5)
Ki67 score
<20% 2 (2.5)
>20% 59 (74.7)
Unknown 18 (22.8)

BCS = breast conservation surgery; ALND = axillary lymph node dissection; SLN = sentinel lymph node biopsy; T0 = main tumour could not be found; T1 = tumour of ≤2 cm; T2 = tumour of 2.1–5 cm; T3 = tumour of >5 cm; T4 = tumour of any size with invasion or adherence to pectoralis muscle, skin ulceration, skin oedema and inflammatory carcinoma; N0 = absence of nodal involvement; Nmic = node micrometastases; N1 = metastasis to 1–3 ipsilateral axillary lymph nodes; N2= metastasis to 4 –9 ipsilateral axillary lymph nodes; N3= metastasis to ≥10 axillary lymph nodes, infraclavicular lymph nodes; pCR = complete pathological response.